News: Baxter International Inc (BAX)

BAX on New York Consolidated

71.69USD
23 May 2013
Price Change (% chg)

$-0.61 (-0.84%)
Prev Close
$72.30
Open
$71.85
Day's High
$72.15
Day's Low
$71.55
Volume
851,179
Avg. Vol
3,616,432
52-wk High
$73.95
52-wk Low
$48.98

Search Stocks
Select another date:

Tue, May 7 2013

Baxter's Alzheimer's disease drug fails in late-stage trial

NEW YORK - In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.

Continue Reading

UPDATE 2-Baxter's Alzheimer's disease drug fails in late-stage trial

* Baxter to stop late-stage studies of the drug for mild to moderate Alzheimer's

BRIEF-Baxter shares down after drug fails in late-stage trial

NEW YORK, May 7 - Baxter International Inc : * Shares down 2.6 percent in premarket trade after alzeheimer's drug fail

Baxter's Alzheimer's disease drug fails in late-stage trial

May 7 - Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities.

Baxter posts lower earnings on acquisition-related expenses

- Baxter International Inc on Thursday said quarterly net earnings fell slightly, as expected, on acquisition-related costs.

UPDATE 2-Baxter posts lower earnings on acquisition-related expenses

* Strength in Bioscience division offset weakness in medical products unit

Baxter posts lower earnings on acquisition-related expenses

- Baxter International Inc on Thursday said its quarterly net earnings fell slightly, as expected, on acquisition-related costs.

Baxter posts lower earnings on acqusition-related expenses

April 18 - Baxter International Inc on Thursday said its quarterly net earnings fell slightly, even as sales rose, as acquisition-related costs ate into profits.

Manatee death toll rises in Florida even as toxic algae ebbs

TAMPA, Florida - A deadly algae bloom that killed a record number of manatees has dissipated, though the death toll for the endangered sea mammals continues to rise, Florida wildlife officials said on Thursday.

Baxter profit higher; sales seen rising 10 percent in 2013

- Medical device and bioscience company Baxter International Inc reported higher quarterly earnings on Thursday and forecast sales growth of 10 percent for 2013.

Select another date:

Market Views

» More BAX Market Views

Press Releases

Search Stocks